Development and Validation of a Nomogram for Predicting the Severity of Coronary Artery Disease Based on

Hongmin Wang1, Yi Wang1, Qingmin Wei2

  • 1Department of Cardiology, The First Hospital of Xingtai, Xingtai, Hebei Province, People's Republic of China.

Insights

A new nomogram using cardiopulmonary exercise testing (CPET) accurately predicts coronary artery disease (CAD) severity. This noninvasive tool aids clinicians in assessing patient risk and guiding treatment decisions for better outcomes.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Medical Diagnostics

Background:

  • Coronary artery disease (CAD) is a significant global health issue requiring precise, noninvasive diagnostic tools.
  • Cardiopulmonary exercise testing (CPET) offers a method for assessing CAD severity and guiding treatment decisions.

Purpose of the Study:

  • To develop and validate a nomogram utilizing CPET parameters for the noninvasive prediction of CAD severity.
  • To assist clinicians in more effectively assessing patient conditions and stratifying risk.

Main Methods:

  • A cohort of 525 patients was analyzed, divided into training (367) and validation (183) groups.
  • Least Absolute Shrinkage and Selection Operator (LASSO) regression identified key predictors of CAD severity from 25 variables.
  • A predictive nomogram was constructed and evaluated using C-index, AUC, calibration curves, and decision curve analysis (DCA).

Main Results:

  • Six significant predictors of CAD severity were identified: age, high-density lipoprotein (HDL), hypertension, diabetes mellitus, anaerobic threshold (AT), and peak oxygen uptake (VO2/kg).
  • The nomogram demonstrated strong diagnostic accuracy with AUC values of 0.939 in the training cohort and 0.840 in the validation cohort.
  • The nomogram showed significant clinical utility and reliability in assessing CAD severity.

Conclusions:

  • The developed nomogram, based on CPET parameters, is a reliable tool for noninvasively predicting CAD severity.
  • This personalized, noninvasive approach aids in risk stratification and supports clinical decision-making for CAD management.